US 9951017
S1P3 antagonists
granted A61PA61P29/00
Quick answer
US patent 9951017 (S1P3 antagonists) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P29/00